Headline News about Takeda Pharmaceutical Ltd ADR
![](https://g.foolcdn.com/editorial/images/722485/dividend-bank-roll.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/21/takeda.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://g.foolcdn.com/editorial/images/720578/vaccine-with-world-map.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.pixabay.com/photo/2016/12/13/22/15/chart-1905225__340.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/23/hcm_0.png?width=1200&height=800&fit=crop)
HUTCHMED Out Licenses Fruquintinib To Takeda Outside China
January 23, 2023
Via Benzinga
A Bullish Sign Appears On Takeda Pharmaceutical's Chart
December 28, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/13/takeda.png?width=1200&height=800&fit=crop)
Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B
December 13, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/02/tak_logo_light__f29805fe51ef567f596f8e65b889fae3.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/06/death-stocks-to-sell.jpg)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://cdn.benzinga.com/files/images/story/2023/01/24/finch-short-logo-l-png.png?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
Via Talk Markets
![](https://cdn.benzinga.com/files/images/story/2022/11/23/takeda.png?width=1200&height=800&fit=crop)
Takeda's Dengue Vaccine Candidate Under FDA Priority Review
November 23, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/27/takeda.png?width=1200&height=800&fit=crop)
Takeda Posts Lower 1H Profit, Lifts FY22 Outlook
October 27, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/09/arwr_logo_light__622e712862838745f5772844be5cb182.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2019/01/stock-gene-03-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/14/theseus_h_investors2.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/09/logo_dark__c424d3ab0271f3cf1e0eea9f187b0781.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/710651/laboratory-space.jpg)
![](https://www.investors.com/wp-content/uploads/2022/11/Stock-arrowheadpharma-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/22/screenshot_2022-11-22_at_7.24.03_pm.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/710337/a-scientist-uses-a-pipette-to-work-with-medical-samples.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/17/1600x900.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/709201/people-reviewing-financials-on-a-screen.jpg)
![](https://g.foolcdn.com/editorial/images/707488/gettyimages-1014182354.jpg)
![](https://investorplace.com/wp-content/uploads/2020/11/dividends-1600.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.